EDGAR·FLOW

Definitive Healthcare Corp. — Form 8-K

Filed November 5, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 78/100
What the filing says
Q3 2026 revenue declined 9% YoY to $54.7M (vs. $60.0M in Q3 2025); net loss improved to $(5.4)M (10% of revenue) from $(17.8)M (30% of revenue) YoY. On September 2, 2026, Advent International submitted a non-binding indication of interest to acquire all outstanding Class A shares and LLC interests not already owned by Advent or founder Jason Krantz. The company suspended financial guidance and cancelled its earnings call due to this development. Adjusted EBITDA was $15.7M (29% margin) vs. $18.9M (32% margin) YoY.
Why this rating

Potential acquisition materially significant to $153.8M market-cap company; revenue decline concerning, but pending deal creates uncertainty outweighing operational metrics.

Price action (we called it neutral)
before filing · preread
$1.13 ▼ 2.59%
at our read · unknown
$1.16
+10 min · unknown
$1.16 ▲ 0.00%
+30 min · unknown
$1.17 ▲ 0.43%
+1 hr · unknown
$1.16 ▼ 0.43%
+4 hrs · unknown
$1.16 ▲ 0.00%

The stock had already moved +2.65% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ DH · stock on Yahoo Finance ↗

See more from November 5, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.